2410 results about "Spot urine" patented technology

A urine collection device includes a collection member extending from a proximal end to a distal end. The proximal end includes an opening that provides access to an internal cavity of the collection member. The internal cavity includes a first chamber in fluid communication with a second chamber. The urine collection device includes a spacer in the second chamber, a first attachment member extending from a bottom wall of the collection member at the proximal end., a second attachment member extending from a top wall of the collection member at the proximal end, and an outlet for egressing urine from the internal cavity of the collection member. The first attachment member defines an aperture. The collection member is suitable to (i) direct urine from the first chamber to the second chamber and (ii) direct the urine in the second chamber distally toward the outlet.

Examples relate to devices, systems, and methods for fluid collection such as urine. The urine collection device includes a fluid impermeable barrier and a fluid permeable body. The fluid impermeable barrier at least partially defines a chamber. The fluid impermeable barrier includes at least one elongated portion having a first width and distal to the aperture and a second portion having a second width greater than the first width. The second portion at least partially defines an opening in the fluid impermeable barrier, and the opening has a maximum lateral dimension greater than the first width of the elongated portion. The fluid permeable body is configured to wick fluid away from the opening into the at least one elongated portion.

An automated urinary output monitoring system includes a urine collection assembly, a scale, and a pump. The urine collection assembly includes a urinary catheter coupled to a first drainage tube. The interim container coupled to the first drainage tube and a second drainage coupled to a final container. The scale measures the weight of urine collected in the final container and a display can depict the volume of urine collected in the final container. A vacuum pump can be coupled with the final container to draw urine from the interim container into the final container, and an air vent can isolate the patient from the vacuum within the final container. The system can be configured to wirelessly transmit urine volume data to an external computing device. A gyroscope can be coupled with the scale to determine the orientation of the scale.

Disclosed herein is a urinary catheter system including a urinary catheter, a drainage tube connecting the urinary catheter to a urine collection bag. The urine collection bag is configured to transition between a storage state and a usage state. The urine collection bag includes an intake port coupled to a first opening, an outlet, where the outlet is configured to transition from a closed state to an opened state to allow the volume of fluid to be displaced from the urine collection bag. A storage bag detachably coupled to the urine collection bag, the storage bag having a storage bag opening and configured to receive the male urinary catheter, the drainage tube, and the urine collection bag in the storage state.

Disclosed herein is a urine collection bag, system, and methods directed to automated measurement of a quantity of urine. The urine collection system can include the urine collection bag, a catheter, and flexible drainage tubing. The urine collection bag can include a collection area, force sensors, and circuitry configured to determine the volume of urine in the collection area based on pressure or weight measured by the force sensors, and the specific gravity of the urine. The catheter may include a small female external catheter (FEC) with an opening on a top side, a wicking catheter with a wicking area on a top side, a finger-mountable catheter, or a male external catheter (MEC). The tubing may be secured to a patient's leg with a stabilization device or a fabric strap. The catheter can remain on a patient while the patient stands or walks.

The invention discloses a blood, urine and body fluid collecting, detecting, analyzing and uploading system based on multi-sensor integration, which comprises the following modules: a blood collecting module for collecting a blood sample; the urine collection module is used for detecting urine; the body fluid collecting module is used for detecting body fluid; the data processing module is used for preprocessing data; the feature extraction and classification module is used for constructing a multi-modal feature matrix based on a neural structure search network, a support vector machine and a random forest algorithm; the anomaly detection module is used for generating a weighted anomaly score in combination with an isolated forest and a depth anomaly detection model; the time sequence analysis module is used for analyzing the health trend by using a variational auto-encoder-generative adversarial network; the health portrait and risk assessment module is used for constructing a health map by adopting a graph convolutional network; and the encryption and uploading management module is used for encrypting by using AES and RSA and managing the data access authority based on the intelligent contract. According to the invention, a multi-modal sensor and an intelligent algorithm are integrated, and collection, detection, analysis, encryption and uploading of blood, urine and body fluid are realized.

The invention belongs to the field of biomedicine, and particularly relates to application of CRYL1 protein in preparation of a product for evaluation, diagnosis or auxiliary diagnosis of postoperative recurrence risk of calcium oxalate kidney stone combined with renal nipple calcium spot, and the sequence of the CRYL1 protein is shown as SEQ ID NO.1. The invention discovers that the expression of the CRYL1 protein in renal tubules and collecting tube cells of renal papillary calcium spot tissues is reduced for the first time, and tests prove that the urine CRYL1 protein is a predictive factor and a predictive marker for postoperative recurrence of a patient with CaOx kidney stone combined with renal papillary calcium spot. The CRYL1 protein detection kit is further researched and developed to be used for detecting or evaluating the postoperative recurrence risk of patients suffering from CaOx kidney stone combined with renal nipple calcium spots, personalized follow-up visit and prevention schemes of the patients are promoted, and the CRYL1 protein detection kit has huge clinical application prospects.

The present invention provides a method for evaluating urinary system diseases based on urine detection, which belongs to the technical field of urology. The method for evaluating urinary system diseases based on urine detection comprises: adding corresponding reagents to three urine samples in sequence according to a preset time point sequence, and obtaining urine sample images after each addition of the reagents; performing image preprocessing on each acquired urine sample image, extracting image features including color changes, sediment morphology and distribution; establishing a time series feature data set, arranging and combining the image features corresponding to each time point in time sequence; using a pre-trained image recognition model to analyze the image features in the time series feature data set, and obtaining feature vectors; the method can solve the problems of high examination cost, great trauma, long examination time, limited diagnostic accuracy, etc. that the existing means of diagnosing urinary system diseases generally have.

Examples relate to systems, devices, and methods for removing fluid from a fluid collection device using a vacuum source operably coupled thereto. The fluid collection devices include urine collection devices having shape memory material that may be selectively shaped to complement the female or male anatomy near the respective urethras.

Disclosed are automated urinary output (“UO”)-measuring systems and methods. An automated UO-measuring system can include a container configured to collect a fluid such as urine. The container can include a console, one or more ultrasonic sensors coupled to the console for determining a fluid level within the container, one or more accelerometers coupled to the console for determining a near-zero acceleration state of the container for the determining of the fluid level within the container, and a valve configured to pass fluid therethrough by way of a fluid line coupled to the valve. The automated UO-measuring system can also include a container holder. The container holder can have a pocket for holding the container and a sleeve for securing the container to a user. A method of the automated UO-measuring system can include a method of using the automated UO-measuring system to collect and measure urine output of the user.

Devices, methods and systems are disclosed for monitoring and analysis of bodily emissions emitted from a user. The device comprises at least an image capturing apparatus, at least one light emission source and, at least one sensor for capturing and monitoring excreta and urine from the user. An artificial intelligence based analysis system is utilized to process data collected from the device and determined at least one parameter based on the analysis. The determined parameter determines health-related information, which is communicated to the user via a user interface.

The ureter and urine bag comprises a urine bag body, a spiral pipe, a connecting pipe, a threaded connector pipe and a urine guiding pipe, the threaded connector pipe comprises a pipe body and an insertion pipe, internal threads with the thread pitch being 1.8-2.2 mm are machined on the inner wall of the pipe body, external threads matched with the internal threads are machined on the outer wall of the insertion pipe, and the spiral pipe is connected with the connecting pipe. Two groups of wing plates are symmetrically arranged on the outer wall of the cannula to provide rotating acting points, and a collecting assembly is integrated on the side wall of the urine bag and used for aseptically collecting urine samples. Traditional plug-pull type connection is replaced by a precise thread fit structure, a clear rotating force application point is provided for medical staff, operation is labor-saving and convenient, connector pollution is avoided, the urinary tract infection risk is effectively reduced, and the nursing comfort of a patient is improved.

The invention discloses a method for detecting the contents of VMA, HVA and 5-HIAA in urine by using liquid chromatography-tandem mass spectrometry. The method comprises the following steps: S1, removing VMA, HVA and 5-HIAA in urine to obtain a blank urine matrix; s2, weighing VMA, HVA and 5-HIAA solid powder, fixing the volume with methanol, mixing the dissolved liquids, diluting with methanol-water to obtain a VMA, HVA and 5-HIAA working solution, and finally diluting step by step with a blank urine matrix to obtain a calibration product; s3, respectively taking a urine sample to be detected, the calibration substance and the quality control substance, adding the mixed internal standard working solution of VMA, HVA and 5-HIAA isotopes, uniformly mixing, centrifuging, and taking supernate; s4, separating the supernate by using liquid chromatography; s5, the separated supernate enters a mass spectrum to be detected, and the content of VMA, HVA and 5-HIAA in the urine sample to be detected is obtained. The detection method disclosed by the invention is simple and rapid in pretreatment, high in specificity, low in reagent consumption cost, free of environmental pollution, small in required sample size, easy in high-throughput operation and suitable for being developed into a kit for conventional clinical detection.

The invention discloses a sepsis-related acute kidney injury intelligent prediction system and a hierarchical management method, and the system comprises a multi-modal data collection module which synchronously collects an ultrasound contrast video, a urine biomarker and hemodynamic parameters in real time; the spatio-temporal feature extraction module is used for extracting multi-modal spatio-temporal features; modeling a dynamic interaction effect of heart and kidney nodes through a dynamic organ interaction graph network; the self-supervised pre-training module is used for improving the generalization of the model through comparative learning; the dynamic risk prediction module outputs a risk probability curve in the next 24 hours; the hierarchical decision management module is used for generating personalized strategies of liquid management, vasoactive drug adjustment and kidney replacement treatment opportunity; and the interpretability module is used for analyzing the key early warning characteristics based on the SHAP value. According to the method, the problems of deficiency of organ interaction modeling, poor generalization of small samples, stiffness of static decision and the like are solved, and the early warning and precise treatment capabilities of the sepsis-related kidney injury are remarkably improved.

The invention discloses midstream urine collection equipment with high sealing performance, belongs to the technical field of midstream urine collection, and aims to solve the problems that a patient cannot accurately control the urination rhythm, so that the boundary between forepart urine and midstream urine is fuzzy, the collected midstream urine contains part of forepart urine, and the midstream urine collection accuracy is influenced. A fixing frame is fixed to the inner side wall of the collecting hopper, a contact plate is arranged on one side of the fixing frame, four evenly-distributed positioning columns are fixed to the side, close to the fixing frame, of the contact plate, and the positioning columns are movably connected to one side face of the fixing frame; after the contact plate is impacted by urine, impact force can be transmitted to the pressure sensor, the impact force of the urine can be detected through the arranged pressure sensor, and then the pressure sensor is matched with the PLC to distinguish anterior urine, midstream urine and posterior urine, so that the boundary distinguishing between the midstream urine and the anterior urine is obvious, and the accuracy of urine detection is improved. The problem that the accuracy of midstream urine collection is affected due to the fact that the collected midstream urine contains part of anterior urine due to autonomous judgment of a patient is avoided.

A station for a urine analysis device is proposed, the station including a case, intended to be positioned at least partially within the toilet, a housing, within the case, configured to at least partially receive a cartridge comprising a plurality of test supports (e.g. test strips). The cartridge is movable within the housing. The station may also include an optical sensor, a translatory injector and an analyzer (e.g. optical). Various configurations are available.

The invention provides a diabetic nephropathy early warning method, system, equipment and medium, and relates to the technical field of medical data analysis and prediction.The method comprises the steps that multiple urine samples of a user are collected, target urine protein detection is conducted, and multiple urine protein concentrations are obtained; each urine protein concentration is combined with a normal urine protein concentration set to be input into an abnormal data recognition tree, the number of layers of multiple recognition nodes is obtained, and the detection confidence coefficient is obtained through calculation; configuring an abnormal proportion according to the detection confidence coefficient, inputting a plurality of urine protein concentration combination normal urine protein concentration sets into an abnormal data identification tree, deleting urine protein concentrations divided into abnormal data in the abnormal proportion before, and obtaining screened urine protein concentrations; according to the screened urine protein concentration, an auxiliary early warning coefficient is obtained through calculation, and early warning is carried out. The technical problem of low early warning accuracy of diabetic nephropathy in the prior art is solved.

The present invention belongs to the field of medical instruments. Disclosed is a pressure-relief urine bag, comprising: a bag internally provided with a urine storage cavity, wherein an input tube communicating the outside with the urine storage cavity is provided on the bag, and fluid can enter the urine storage cavity through the input tube, but the fluid in the urine storage cavity cannot be drained through the input tube; a warning structure comprising a pressure-sensing member and a vibration member, wherein the pressure-sensing member is electrically connected to the vibration member, the warning structure is connected to the bag, the pressure-sensing member is located in the urine storage cavity, and when the occupied space in the urine storage cavity reaches a set value, the fluid presses the pressure-sensing member and causes the vibration member to vibrate and produce sound; and an output tube, which is connected to the bag at one end, and comprises a manual urine drainage tube and an automatic urine drainage tube, wherein one end of the manual urine drainage tube is in communication with the urine storage cavity. The present invention can alert a patient and medical staff when the urine bag is about to be full of urine, and even if the patient and medical staff fail to notice and allow the urine bag to fill up, the urine in the bag can still be drained through the automatic urine drainage tube, thereby effectively preventing leakage or bursting caused by excessive pressure in the urine bag.

Disclosed here are kits comprising pre-packed stabilizing solutions for stabilizing combinations of biomarkers demonstrating sufficient accuracy and specificity for identifying kidney injuries. Such kits can be better adapted for sample collection at a subject's dwelling, thus easing the burdensome requirement of continuous monitoring for kidney injury.

The invention relates to application of an aminated beta-cyclodextrin composite material and a method for simultaneously analyzing endogenous and exogenous organic matters in urine by using the aminated beta-cyclodextrin composite material. According to the method, the cellulose-loaded aminated beta-cyclodextrin composite material is used as a solid-phase extraction agent for the first time, the endogenous markers in the urine are efficiently extracted, and the combined analysis of the endogenous markers and the exogenous markers is realized at the same time. A target compound can be efficiently extracted from a complex urine matrix through an optimized solid-phase extraction process which comprises the steps of activation, sample loading, drying, elution, nitrogen blowing and the like. Then, a liquid chromatography-mass spectrometry technology is utilized for analysis, qualitative and quantitative analysis is performed on 80 target objects in a multi-reaction monitoring (MRM) mode, and the method has good recovery rate (60%-130%) and excellent stability and repeatability.

The paper diaper comprises a skin-friendly layer, a urine absorption product and a liquid-tight bottom layer which are sequentially arranged in a stacked mode, a waistline leakage-proof structure is arranged between the skin-friendly layer and the liquid-tight bottom layer, and the urine absorption product is arranged in an interlayer area between the skin-friendly layer and the waistline leakage-proof structure. The auxiliary core body and the main core body in the urine absorption product contain super water-absorbent resin in different proportions, the layered design is beneficial to rapid absorption of urine and prevention of back seepage, the leakage-proof performance is improved, the liquid-leakage-proof middle layer located at the bottom of the urine absorption product can isolate the main core body from the liquid storage core body, and the leakage-proof performance of the urine absorption product is improved. The main core body can bear a large amount of urine flowing out suddenly, so that the liquid storage core body cannot be polluted and lose efficacy, when the urine absorption product loses efficacy in side leakage prevention, solute concentration between the flow guide core body and the liquid storage core body is not uniform, surface tension changes accordingly, and due to the fact that the surface tension of liquid with different concentrations is different, the urine absorption product cannot be polluted. This may cause the liquid to flow along areas with lower surface tension.

The invention discloses a urine sampling device for the endocrinology department and a sampling method, and belongs to the technical field of medical analysis. Comprising the following modules: an automatic sampling control module for realizing automatic control of the whole urine sampling process, ensuring that sampling accords with a standard process, and supporting automatic sub-packaging and storage management of samples; the sample quality control module is used for monitoring the physical characteristics of the samples in real time, automatically evaluating the effectiveness of the samples in combination with environmental parameter monitoring, and identifying and marking abnormal samples; the data acquisition and processing module is used for comprehensively acquiring physiological data, nutrition metabolism data, operation process data and sample tracing information, and performing cleaning, standardization and fusion processing to generate a standardized data set; the intelligent diagnosis and analysis module is used for intelligently detecting abnormal physiological indexes and carrying out disease risk prediction and early warning; and the man-machine interaction module provides a visual operation interface and integrates multi-level user authority management, automatic report generation and remote monitoring.

Featured are urodynamic catheters, intravaginal devices, and intrarectal devices, systems and kits thereof, and methods of using the devices, systems, and kits to observe pelvic floor movements in order to monitor bladder function in order to diagnose, treat, or prevent urinary incontinence disorders, such as urge incontinence and stress incontinence.

The invention provides a kit and a method for simultaneously detecting 11 pathogens of a urogenital system and application, and belongs to the field of molecular biology. The primer group is used for detecting urogenital tract pathogens, and the urogenital tract pathogens comprise ureaplasma urealyticum (UU), chlamydia trachomatis (CT), mycoplasma genitalium (MG), ureaplasma parvum (UP), mycoplasma hominis (MH), adenovirus (ADV), trichomonas vaginalis (TV), herpes simplex virus type I (HSV-I), herpes simplex virus type II (HSV-II), haemophilus influenzae (HI) and neisseria gonorrhoeae (NG). The primer group is used for multi-joint detection of non-gonococcal urethritis related pathogens, has high specificity and sensitivity, is adaptive to non-invasive urine specimens, and supports home self-sampling. The kit is used for clinical diagnosis and can quickly judge pathogen types. Precise medication is performed based on a detection result, the healing time of a patient is shortened, the burden of a doctor is relieved, and meanwhile the pathogen transmission risk is reduced.

The invention discloses a multi-channel liquid output monitoring device capable of identifying colors, and relates to the technical field of medical devices. One end of a catheterization channel enters a bladder through a urethra, and the other end of the catheterization channel is communicated with a urine storage bag; the urine flow of the urine guide channel is monitored through a flow sensor, and the urine color of the urine guide channel is monitored through an optical sensor; comparing with a normal urine standard range; when the monitored urine flow and / or urine color exceed a normal range, an alarm is given out through the alarm device to remind medical staff and / or a patient to pay attention and treat; a plurality of branch channels are further arranged on the urinary catheterization channel, each branch channel is provided with a first switch, and when it is recognized that the urine flow and / or the urine color are / is abnormal, the first switch is turned on, so that urine enters the branch channels for sample reserving, and it is avoided that it is difficult to observe and sample the urine at the same time or at different time periods; the branch channels are opened when urine is recognized to be abnormal, so that the abnormal urine is pertinently stored, and the number of the branch channels is effectively reduced.

Doubly labeled water with enhanced protocol. One embodiment is a method including providing, to a user, a doubly labeled water (DLW) dose for the user to ingest, the DLW dose including deuterium and oxygen-18, wherein an amount of the deuterium is less than 0.12 grams per kilogram (g / kg) of body water of the user, and wherein an amount of the oxygen-18 is less than 0.18 g / kg of body water of the user. The method also includes receiving, from the user, a non-cooled shipment of urine samples collected in connection with ingestion of the DLW dose, wherein the urine samples remain uncooled after collection and during transit for a period of up to 24 days. The method further includes processing the urine samples with a liquid water isotope analyzer to determine one or more metabolic parameters of the user.

The invention relates to methods, devices, and software for distinguishing hemoglobin (Hb) from myoglobin (Mb) in urine samples using peroxidase-reactive test strips. A time-resolved video of the color change on the test pad is recorded, and hue values are extracted and analyzed over time. Diagnostic differentiation between Hb and Mb is achieved by evaluating the hue-time curve, in particular via endpoint hue values and the ratio of integrated hue values in distinct time intervals. The invention further comprises a standardized optical setup for recording, a software-based evaluation algorithm, and a refillable cartridge for in-situ urine analysis devices containing appropriate test fields. The invention enables combined testing with additional urine parameters and is suitable for medical and non-clinical applications such as sport and home diagnostics.

A urine management device includes a collection chamber hingedly coupled to a base. The base includes a proximal side and a distal side. The proximal side of the base is configured to contact a pelvic area of a user and the distal side faces the collection chamber. During application, the collection chamber can be folded out of the way, allowing a clinician full access to adhere the base to the pelvic area of the user. Once the base is securely adhered to the pelvic area of the user, the collection chamber can be folded back and coupled to the distal side of the base, creating a secure seal. The collection chamber is configured to (i) collect urine exiting an anatomy of the user and (ii) direct the urine in the collection chamber toward an outlet.

The invention relates to the technical field of medical health monitoring, and discloses a urine volume detection system based on a strain gauge type sensor, which comprises a urine collection container, a strain gauge type sensor, an electromagnetic valve, a main controller and an infrared human body sensor, the upper port of the urine collecting container is used for receiving urine, and the lower port of the urine collecting container is connected with the strain gauge type sensor; the strain gauge type sensor is used for detecting the weight change of the urine collection container, the urine volume detection system based on the strain gauge type sensor and the intelligent closestool overcome the defect that a traditional closestool cannot measure and record the urine volume, convenience is brought to patients who do not want to use a urinal or a pedestal pan and old people with poor eyesight, and the intelligent closestool is convenient to use. A user can know the urine volume when using the closestool or pouring urine into the urinal into the closestool, use is convenient and sanitary, accurate urine volume data helps a doctor to formulate a more accurate medication scheme for a patient, and the patient is prevented from seeing a doctor repeatedly and the health risk caused by medicine problems.

The invention relates to the field of medical apparatus and instruments, in particular to a catheter outer clamping type urine volume monitoring device and method.The catheter outer clamping type urine volume monitoring device comprises a clamping body module capable of being controlled to be opened and closed and used for detachably wrapping the outer wall of a catheter; the sensing module is integrated on the inner surface of the clamping main body module and comprises a flow velocity detection unit used for acquiring a urine flow velocity signal based on an ultrasonic time-difference method; the deformation detection unit is used for acquiring peripheral deformation distribution of the urinary catheter through contact type pressure sensing; the parameter calibration module comprises a non-contact optical measurement assembly and is used for acquiring geometric parameters of the ureter before and after the clamping operation; the control module is in communication connection with the sensing module and the parameter calibration module and is used for dynamically adjusting the clamping pressure according to the geometric parameters; and fusing the flow velocity signal and the deformation distribution data to generate a calibrated urine flow value. According to the invention, high-precision and multi-dimensional urine volume monitoring is realized, and the system adapts to a complex flowing state.